D. Antoniou
Impact in
- Biomaterials top 10%
- Nanoparticle-Based Drug Delivery
-
- Lung Cancer Research Studies
- Cancer Treatment and Pharmacology
Papers in
-
- Lung Cancer Treatments and Mutations 7
- Lung Cancer Diagnosis and Treatment 3
- Oncology 10
- Lung Cancer Research Studies 10
- Cancer Treatment and Pharmacology 3
- Co-authors
- George P. Stathopoulos (10 shared papers)J. Dimitroulis (11 shared papers)J. Stathopoulos (6 shared papers)M. Veslemes (6 shared papers)Niki Georgatou (5 shared papers)Ioannis Karydis (1 shared paper)Dimitrios Veldekis (1 shared paper)M. Toubis (2 shared papers)
In The Last Decade
D. Antoniou
15 papers receiving 351 citations
Peers
Comparison fields: 5 of 62
- Biomaterials 110
- Oncology 180
- Internal Medicine 24
- Pulmonary and Respiratory Medicine 140
- Biomedical Engineering 80
Countries citing papers authored by D. Antoniou
This map shows the geographic impact of D. Antoniou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D. Antoniou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D. Antoniou more than expected).
Fields of papers citing papers by D. Antoniou
This network shows the impact of papers produced by D. Antoniou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D. Antoniou. The network helps show where D. Antoniou may publish in the future.
Co-authors
The 25 scholars most cited alongside D. Antoniou, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2010 | 90 | |
| 2 | 2011 | 83 | |
| 3 | 2006 | 61 | |
| 4 | 2004 | 50 | |
| 5 | 2005 | 20 | |
| 6 | 2005 | 12 | |
| 7 | 2005 | 9 | |
| 8 | 2010 | 8 | |
| 9 | 2009 | 7 | |
| 10 | Mesothelioma: treatment and survival of a patient population and review of the literature. | 2005 | 7 |
| 11 | Phase II study of cisplatin-combined schedules as second-line chemotherapy in patients with non-small cell lung cancer. | 2005 | 5 |
| 12 | Alternate paclitaxel-gemcitabine and paclitaxel-vinorelbine biweekly administration in non-small cell lung cancer patients: a phase II study. | 2006 | 4 |
| 13 | 2007 | 1 | |
| 14 | 2010 | 1 | |
| 15 | 2010 | 1 |
About D. Antoniou
D. Antoniou is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Molecular Biology, Hepatology and Radiology, Nuclear Medicine and Imaging, having authored 15 papers that have together received 359 indexed citations. Recurring topics across this work include Lung Cancer Research Studies (10 papers), Lung Cancer Treatments and Mutations (7 papers), Hepatocellular Carcinoma Treatment and Prognosis (4 papers), Cancer therapeutics and mechanisms (4 papers), Cancer Treatment and Pharmacology (3 papers), Lung Cancer Diagnosis and Treatment (3 papers), Atomic and Subatomic Physics Research (2 papers) and Radiation Dose and Imaging (1 paper). The work is most often cited by research in Biomaterials (110 citations), Oncology (180 citations), Internal Medicine (24 citations), Pulmonary and Respiratory Medicine (140 citations) and Biomedical Engineering (80 citations). D. Antoniou has collaborated with scholars based in Greece, Romania and China. Frequent co-authors include George P. Stathopoulos, J. Dimitroulis, J. Stathopoulos, M. Veslemes, Niki Georgatou, Ioannis Karydis, Dimitrios Veldekis, M. Toubis, D. Tsavdaridis and S. Rigatos. Their work appears in journals such as Journal of Clinical Oncology, Cancer Chemotherapy and Pharmacology, Annals of Oncology, British Journal of Cancer and Oncology Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.